Watson launches generic contraceptive

PARSIPPANY, N.J. — Watson Pharmaceuticals has launched a generic version of a contraceptive made by Warner Chilcott, Watson said Monday.



The drug maker announced the launch of chewable norethindrone and ethinyl estradiol tablets in the 0.4-mg/0.035-mg strength and chewable ferrous fumarate tablets in the 75-mg strength.



The product is a generic version of Warner Chilcott's Femcon Fe, which had sales of about $35 million during the 12-month period ended in July, according to IMS Health.

Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.